![]() Have you filled out our Guestbook? If not, please do.Ĭopyright © 1997 - 2022. Xiaflex continues to be the main stock driver for AUXL. All of the conditions to the Offer have been satisfied, and on December 2, 2020, Endo accepted for payment, and will as promptly as practicable pay for, all shares validly tendered and not validly withdrawn.Īddress: 35 Wilbur Street, Lynbrook, NY 11563įind a problem? Please use our Feedback Page or Email us. Jefferies is maintaining its 36 PT on shares of Auxilium Pharmaceuticals, Inc. Computershare Trust Company, N.A., the depositary and paying agent for the Offer, reported that approximately 6,159,975 shares of BioSpecifics’ common stock were validly tendered and not validly withdrawn, representing approximately 82.8% of the outstanding shares of BioSpecifics’ common stock on a fully diluted basis. (NASDAQ: BSTC) (the “Company” or “BioSpecifics”), a biopharmaceutical company that originated and continues to develop collagenase-based therapies with a first-in-class collagenase-based product marketed as XIAFLEX® in North America, today announced the successful completion of its acquisition by Endo International plc (“Endo”) for approximately $658.2 million in equity value.Įndo’s all-cash tender offer (the “Offer”) to acquire all of the issued and outstanding shares of BioSpecifics’ common stock at a purchase price of $88.50 per share expired one minute after 11:59 p.m., New York time, on December 1, 2020. Notes: Decem– BioSpecifics Technologies Corp. The philanthropic cryptocurrency company Auxilium Global launched the Auxilium blockchain mid 2018, and created the Auxilium (AUX) coin. of 30 degrees or greater at the start of therapy by BioSpecifics partner, Auxilium Pharmaceuticals. The Company is with the Russell 3000 and Russell Global Indexes as part of Russell Investments' annual reconstitution of its U.S. Ticker Symbol: BSTC CUSIP: 090931106 Exchange: NGM. Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, focuses on developing and marketing products to urologists, endocrinologists, orthopedists, and primary care physicians. (Nasdaq: AUXL) are surging 18 higher after positive FDA briefing documents on the companys XIAFLEX drug to treat Dupuytrens contracture. for the treatment of adult Dupuytren's contracture patients with a palpable cord in the palm and for Peyronie's disease in men with a palpable plaque and a curvature deformity of 30 degrees or greater at the start of therapy by BioSpecifics' partner, Auxilium Pharmaceuticals, Inc. Injectable collagenase is approved for marketing as XIAFLEX (collagenase clostridium histolyticum or CCH) in the U.S. For those to whom the issue may seem cosmetic, roughly 52% of Peyronie's sufferers report erectile dysfunction and pain and are likely to really, really want the treatment.* NOTE: This security is no longer trading as of Ĭompany's Online Profile BUSINESS: BioSpecifics Technologies Corp.is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. For Peyronie's, at least 130 patients a year fit the "30 - 90 degree curvature" criteria of the ideal patient, utilized in the IMPRESS trial. Markets include NASDAQ, NYSE, OTCBB, Pink Sheet, cryptocurrency and world exchanges. In the case of Dupuytren's, for which Xiaflex is already approved, 95%+ of patients are reimbursed under common insurance schemes. FREE stock and cryptocurrency quotes, message boards, fundamentals. ![]() The total cost of treatment per patient is expected to be US$ 40,000, and there is no news yet on whether insurers are willing to cover the costs. import time import urllib2 from urllib2 import urlopen sp500 a, aa, aapl, abbv, abc, abt, ace, aci, acn, act, adbe, adi, adm, adp. Stock analysis for Auxly Cannabis Group Inc (CBWTF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The future of Xiaflex for this new indication is not yet certain. AUXL (AUXL) Stock Price, News & Historical Data - TheStreet - TheStreet AUXL AUXL AUXL News MERGERS AND ACQUISITIONS BSX ENDP Boston Scientific Buys Endo's Urology Device Business in 1.6. Each treatment cycle consists of two Xiaflex injection procedures (in which Xiaflex is injected directly into the collagen-containing structure of the penis) and one penile modeling procedure performed by the health care professional." ![]() According to the FDA, " treatment course for Peyronie’s disease consists of a maximum of four treatment cycles.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |